COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 81: Articles 801-810  | Next

Intranasal AAV Vaccination of SARS-CoV-2 Induce Strong and Sustained Neutralizing Antibodies in Mice
Ji, Y., Di Pasquale, G., Zheng, C., Afione, S., Esperanza, T., Yin, H., Burbelo, P. D., Chiorini, J. A.
10.1101/2025.03.14.640671 — Posted: 2025-03-14
Implementation of a multiplex PCR amplfication system combined with next-generation genome sequencing to decipher the circulation of Human coronavirus 229E lineages in Southern France
HIKMAT, H., PY, J., BOSCHI, C., BUREL, E., LE TARGA, L., MILLION, M., LESAGE, L., MORAND, A., LA SCOLA, B., COLSON, P.
10.1101/2025.03.12.639729 — Posted: 2025-03-14
Community Perspectives on COVID-19 Vaccine Allocation Ethical Principles in Uganda: A Descriptive Cross-Sectional Study
Kiguli, J., Ssebibubbu, S., Nabaliisa, J., Nalwadda, C., Kirunda, B. R., Kamweri, M.
10.1101/2025.03.12.25323855 — Posted: 2025-03-13
Evidence of health-system resilience in the uptake of antiretroviral therapy in Sierra Leone during the COVID-19 pandemic: a nationwide retrospective study
Tucker, J., Marah, J., Egesimba, G., Mekonnen, Z. A., Sheriff, H., Molleh, B., Sevalie, S., Chan, A. K., Mishra, S., Lakoh, S.
10.1101/2025.03.12.25323867 — Posted: 2025-03-13
Optimising COVID-19 Episode Identification Using Serology and PCR/Rapid Antigen Testing: Insights from the BRACE Trial
McDonald, E., Pittet, L. F., Bonten, M., Byrne, A., Campbell, J., Croda, J., Dalcolmo, M. P., Davidson, A., dos Santos, G., Gardiner, K., Gwee, A., Jardim, B. A., Lacerda, M. V. G., Lucas, M., Lynn, D. J., Manning, L., Marshall, H. S., Perrett, K. P., Prat-Aymerich, C., Puga, M. M., Richmond, P. C., Rodriguez-Bano, J., Wadia, U., Warris, A., Wood, N. J., Curtis, N., Messina, N. L., BRACE Trial Consortium Group
10.1101/2025.03.12.25323795 — Posted: 2025-03-13
Few-Shot Viral Variant Detection via Bayesian Active Learning and Biophysics
Huot, M., Wang, D., Liu, J., Shakhnovich, E.
10.1101/2025.03.12.642881 — Posted: 2025-03-13
The proton-activated chloride channel inhibits SARS-CoV-2 spike protein-mediated viral entry through the endosomal pathway.
Koylass, N. R., Sachithanandham, J., Osei-Owusu, J., Chen, K. H., Cheng, H. Y., Pekosz, A., Qiu, Z.
10.1101/2025.03.12.642872 — Posted: 2025-03-13
RNA Architecture Underlies Discontinuous Transcription and Evolution of Coronavirus
Wen, Z., Chen, L., Luo, D., Sun, J., Guo, L., Deng, Y., Huang, Z., Wang, Y., Pan, K., Wang, F., Xiao, S., Li, L., Wei, D.
10.1101/2025.03.13.642953 — Posted: 2025-03-13
A Geographical approach to understand the impacts of Social Determinants of Health on COVID-19 outcomes in an intra-urban context in Sao Paulo State, Brazil
Pereira Caetano de Lima, J. P., Guimaraes, R. B.
10.1101/2025.03.09.25323628 — Posted: 2025-03-12
On-Campus Dormitories as Viral Transmission Sinks: Phylodynamic Insights into Student Housing Networks During the COVID-19 Pandemic
Bolanos, J., Dornburg, A., Harris, A., Kunkleman, S., Ferdous, J., Taylor, W., Schlueter, J., Gibas, C.
10.1101/2025.03.07.25323493 — Posted: 2025-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).